These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 12053153)
1. Danazol therapy for thrombocytopenia in patients with myelodysplastic syndromes. Viniou N; Plata E; Terpos E; Variami E; Meletis J; Vaiopoulos G; Loukopoulos D; Chatzidimitriou G; Yataganas X Acta Haematol; 2002; 107(4):234-6. PubMed ID: 12053153 [No Abstract] [Full Text] [Related]
2. Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome. Chan G; DiVenuti G; Miller K Am J Hematol; 2002 Nov; 71(3):166-71. PubMed ID: 12410570 [TBL] [Abstract][Full Text] [Related]
3. Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases. Wattel E; Cambier N; Caulier MT; Sautière D; Bauters F; Fenaux P Br J Haematol; 1994 May; 87(1):205-8. PubMed ID: 7947249 [TBL] [Abstract][Full Text] [Related]
4. Androgen therapy for patients with lower-risk myelodysplastic syndrome and significant cytopenia: a retrospective study. Choi EJ; Lee JH; Park HS; Lee JH; Seol M; Lee YS; Kang YA; Jeon M; Woo JM; Kang H; Lee KH Br J Haematol; 2019 Oct; 187(1):e4-e7. PubMed ID: 31368111 [No Abstract] [Full Text] [Related]
5. Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy. Hebbar M; Kaplan C; Caulier MT; Wattel E; Morel P; Wetterwald M; Bauters F; Fenaux P Br J Haematol; 1996 Jul; 94(1):112-5. PubMed ID: 8757517 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome. Arber C; Buser A; Heim D; Gratwohl A; Tichelli A; Passweg JR Eur J Haematol; 2006 Mar; 76(3):255-7. PubMed ID: 16451398 [TBL] [Abstract][Full Text] [Related]
12. Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome. Gauchan D; Shaaban H; Gedeon D; Maroules M Ann Hematol; 2014 Oct; 93(10):1777-8. PubMed ID: 24554304 [No Abstract] [Full Text] [Related]
13. Danazol therapy in myelodysplasia. Cines DB; Cassileth PA; Kiss JE Ann Intern Med; 1985 Jul; 103(1):58-60. PubMed ID: 4003989 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of myelodysplastic syndromes with danazol]. Aviles A; García LD; Romero N; Tripp F; González-Llaven J Arch Invest Med (Mex); 1988; 19(1):73-7. PubMed ID: 3228341 [No Abstract] [Full Text] [Related]
17. Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia. Kantarjian H; Fenaux P; Sekeres MA; Becker PS; Boruchov A; Bowen D; Hellstrom-Lindberg E; Larson RA; Lyons RM; Muus P; Shammo J; Siegel R; Hu K; Franklin J; Berger DP J Clin Oncol; 2010 Jan; 28(3):437-44. PubMed ID: 20008626 [TBL] [Abstract][Full Text] [Related]
18. Successful use of rituximab in platelet transfusion refractoriness in a multi-transfused patient with myelodysplastic syndrome. Yu QH; Shen YP; Ye BD; Zhou YH Platelets; 2015; 26(2):195-6. PubMed ID: 23634876 [TBL] [Abstract][Full Text] [Related]
20. Platelet associated IgG may be related with thrombocytopenia in patients with myelodysplastic syndromes. Gilli SC; de Souza Medina S; de Castro V; Fernandes LG; Saad ST Leuk Res; 2012 May; 36(5):554-9. PubMed ID: 22129476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]